AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 384574
Drug: Systemic chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic chemotherapy with 5-fluorouracil (5-FU)
Trial: 6813477
Drug: Auranofin 2
RxNorm normalized name: Auranofin
DrugBank: Auranofin (DB00995)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Auranofin 2 mg daily
Trial: 6813477
Drug: Auranofin 6
RxNorm normalized name: Auranofin
DrugBank: Auranofin (DB00995)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Auranofin 6 mg daily
Trial: 29733414
Drug: ZnAA0 (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ZnAA0 (60 mg Zn/kg from ZnSO4)
Trial: 29733414
Drug: ZnAA60 (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ZnAA60 (60 mg Zn/kg from ZnAA)
Trial: 29733414
Drug: ZnAA90 (90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ZnAA90 (90 mg Zn/kg from ZnAA)
Trial: 29733414
Drug: ZnAA120 (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ZnAA120 (120 mg Zn/kg from ZnAA)
Trial: 29733414
Drug: ZnAA150 (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ZnAA150 (150 mg Zn/kg from ZnAA)
Trial: 29733414
Drug: All ZnAA
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All ZnAA treatments (ZnAA0, ZnAA60, ZnAA90, ZnAA120, ZnAA150)
Trial: 22222634
Drug: Perampanel (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perampanel (4 mg/d)
Trial: 22222634
Drug: Entacapone (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Entacapone (200 mg with each dose of L-dopa)
Trial: 20574018
Drug: Topical 0.45%
RxNorm normalized name: camphor topical 0.45% topical gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 0.45% OT-551 administered three times daily for 2 years
Trial: 16129715
Drug: Forskolin (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Forskolin (250 mg of 10% forskolin extract twice a day)
Trial: 12405362
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (1 g IV as soon as SAH diagnosis was verified, followed by 1 g every 6 hours until aneurysm occlusion, not exceeding 72 hours)
Trial: 12405362
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no tranexamic acid treatment)
Trial: 7771608
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment with AVS
Trial: 2124756
Drug: verapamil, 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: verapamil, 10 mg in 5 minutes (n = 29)
Trial: 2124756
Drug: flecainide, 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: flecainide, 2 mg/kg in 10 minutes (n = 20)
Trial: 2124756
Drug: propafenone, 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: propafenone, 2 mg/kg in 10 minutes (n = 20)
Trial: 463537
Drug: Induction of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction of labour by amniotomy and intravenous oxytocin infusion
Trial: 30055127
Drug: Esomeprazole (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole (40 mg daily)
Trial: 25623736
Drug: Cognitive remediation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive remediation plus standard treatment
Trial: 18401974
Drug: Single intravaginal
RxNorm normalized name: Intravaginal contraceptives
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single intravaginal dose of Polyhexamethylene Biguanide (PHMB)
Trial: 18401974
Drug: Seven daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Seven daily doses of Clindamycin vaginal cream
Trial: 18401974
Drug: Single intravaginal
RxNorm normalized name: Intravaginal contraceptives
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single intravaginal dose of Polyhexamethylene Biguanidine (PHMB)
Trial: 11198264
Drug: 5,000 mg
RxNorm normalized name: garlic 5,000 mg ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5,000 mg ascorbic acid
Trial: 11198264
Drug: Ascorbic acid
RxNorm normalized name: Ascorbic Acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ascorbic acid (all doses)
Trial: 9160496
Drug: Treatment among
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment among compliers
Trial: 8416762
Drug: Amlodipine 2.5‐10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine 2.5‐10 mg once daily
Trial: 8416762
Drug: Nadolol 40‐160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nadolol 40‐160 mg once daily
Trial: 31513531
Drug: Xyla-P cream
RxNorm normalized name: capsaicin Topical Cream [Capzasin-P]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xyla-P cream
Trial: 23559222
Drug: 0.4 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 mg/kg oral yohimbine
Trial: 15901043
Drug: Propranolol (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (40 mg twice daily, n = 7)
Trial: 15901043
Drug: Carvedilol (12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol (12.5 mg once daily for two days and thereafter 25 mg daily, n = 7)
Trial: 15901043
Drug: Tamsulosin (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin (0.4 mg once daily, n = 6)
Trial: 12687534
Drug: Anakinra (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anakinra (100 mg daily by subcutaneous injection)
Trial: 8635937
Drug: Olsalazine 250
RxNorm normalized name: olsalazine 250 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olsalazine 250 mg, two capsules twice daily
Trial: 8635937
Drug: Placebo, two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, two capsules twice daily
Trial: 1615937
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (blood transfusions, antacids, and ranitidine) (group 2)
Trial: 25316469
Drug: Regular intermittent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular intermittent bolus (RIB) - 10 ml of 0.08% ropivacaine + 0.4 ug·ml‐1 sufentanil administered once an hour
Trial: 25316469
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion (CI) - same solution continuously infused at a rate of 10 ml·h‐1
Trial: 10410207
Drug: Treatment A
RxNorm normalized name: Nix Ultra Lice Treatment And Prevention Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment A (diaphragm breathing with incentive spirometry and postural drainage)
Trial: 10410207
Drug: Treatment B
RxNorm normalized name: PanOxyl Acne Treatment Bar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment B (diaphragm breathing with positive expiratory pressure (PEP-mask) and postural drainage)
Trial: 30077350
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg intravenous ibuprofen in 100 mL saline solution
Trial: 30077350
Drug: 100 mL
RxNorm normalized name: PVC IV Bag 100 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mL intravenous saline solution
Trial: 28007113
Drug: Steroid (prednisolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid (prednisolone acetate 1.0% [Pred Forte])
Trial: 15816575
Drug: Remifentanil TCI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil TCI with initial effect site concentration of 1.5 ng mL(‐1)
Trial: 15816575
Drug: Fentanyl TCI
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl TCI with initial effect site concentration of 2 ng mL(‐1)
Trial: 9771182
Drug: 15 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 micrograms (0.3 ml) fentanyl added to 2.5 ml 0.5% hyperbaric bupivacaine
Trial: 9771182
Drug: 0.3 ml
RxNorm normalized name: ethanol 0.3 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 ml 0.9% saline (control group)
Trial: 29482525
Drug: Internet-based grief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-based grief therapy
Trial: 24713286
Drug: Compound whole
RxNorm normalized name: BENZOIN COMPOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compound whole grain-soybean
Trial: 20575206
Drug: Transbond CC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transbond CC
Trial: 17012900
Drug: Hepatitis B
RxNorm normalized name: HEPATITIS B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis B vaccine plus SRL 172
Trial: 17012900
Drug: Hepatitis B
RxNorm normalized name: HEPATITIS B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis B vaccine plus placebo
Trial: 8936627
Drug: Tamsulosin 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin 0.2 mg daily
Trial: 8936627
Drug: Chlormadinone 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlormadinone 50 mg daily
Trial: 8936627
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of tamsulosin 0.2 mg and chlormadinone 50 mg daily
Trial: 8936627
Drug: Tamsulosin 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin 0.2 mg and chlormadinone 50 mg daily
Trial: 24116868
Drug: Ustekinumab dose
RxNorm normalized name: Ustekinumab
DrugBank: Ustekinumab (DB05679)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ustekinumab dose adjustment to 90 mg
Trial: 18220486
Drug: rosiglitazone 4
RxNorm normalized name: rosiglitazone 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosiglitazone 4 mg b.i.d.
Trial: 7294327
Drug: Physostigmine 2
RxNorm normalized name: PHYSostigmine 2 mg/5 mL intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physostigmine 2 mg
Trial: 15819761
Drug: Nefopam 10
RxNorm normalized name: nefopam 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nefopam 10 mg
Trial: 8951965
Drug: Intravenous fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous fentanyl (0.1 mg/70 kg)
Trial: 8951965
Drug: Intravenous midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous midazolam (0.5, 1, and 2 mg per 70 kg) with fentanyl
Trial: 1937995
Drug: Ranitidine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (50 mg intravenously every 8 hours for 3 days, then 150 mg orally in the evening for one month)
Trial: 7380586
Drug: Proquazone (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proquazone (600 mg) after 20 ml of antacid (Maaloxan)
Trial: 7380586
Drug: Proquazone (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proquazone (600 mg) after a standard breakfast
Trial: 31763228
Drug: Lipid based
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid based ointment with tablet Rupatidine 10 mg OD
Trial: 31763228
Drug: Tablet Rupatidine
RxNorm normalized name: ROXATIDINE
DrugBank: Roxatidine acetate (DB08806)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet Rupatidine 10 mg OD alone
Trial: 17051119
Drug: Control areas
RxNorm normalized name: AR-9281
DrugBank: AR-9281 (DB06345)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control areas (no treatment)
Trial: 11078252
Drug: Intravenous ethanol
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ethanol administration (60 ml of 100 proof ethanol)
Trial: 1526058
Drug: Aerosol spray
RxNorm normalized name: Betadine Aerosol Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerosol spray (Otomize)
Trial: 29984804
Drug: Fibroblast growth
RxNorm normalized name: Fibroblast growth factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibroblast growth factor‐2 treatment
Trial: 25663125
Drug: CF-HAIC (Cisplatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CF-HAIC (Cisplatin 60 mg/m2 on day 2, 5-FU 500 mg/m2 on days 1-3)
Trial: 25663125
Drug: ACF-HAIC (Adriamycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACF-HAIC (Adriamycin 50 mg/m2 on day 1, Cisplatin 60 mg/m2 on day 2, 5-FU 500 mg/m2 on days 1-3)
Trial: 22027669
Drug: Topamax (topiramate)
RxNorm normalized name: topiramate Oral Tablet [Topamax]
DrugBank: Topiramate (DB00273)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Topamax (topiramate) as mono-therapy (8 children) and combined therapy (22 children) with a mean treatment dose of 5.9 mg/kg per day
Trial: 17485058
Drug: Conventional gauze
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional gauze therapy
Trial: 16619056
Drug: Oxyntomodulin administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxyntomodulin administration
Trial: 14508884
Drug: MBI-226 gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MBI-226 gel formulation
Trial: 9187996
Drug: Triiodothyronine (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triiodothyronine (4 x 10(‐12) to 1 x 10(‐4) mol/L)
Trial: 9187996
Drug: Triiodothyronine (10(‐9)
DrugBank: Liothyronine (DB00279)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triiodothyronine (10(‐9) to 10(‐8) mol/L)
Trial: 1568371
Drug: Single i.v.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single i.v. administration of 2 g ceftazidime concurrent with anesthesia induction (group 1)
Trial: 1568371
Drug: Short-term prophylaxis
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term prophylaxis with 1 g ceftazidime administered preanesthesia, 30 min before surgery and 6 and 12 hrs after the first dose (group 2)
Trial: 2859775
Drug: Acebutolol 100
RxNorm normalized name: acebutolol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acebutolol 100 mg three times a day
Trial: 2859775
Drug: Acebutolol 200
RxNorm normalized name: acebutolol 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acebutolol 200 mg three times a day
Trial: 2859775
Drug: Acebutolol 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acebutolol 600 mg three times a day
Trial: 2859775
Drug: Propranolol 30
RxNorm normalized name: HCTZ 25/PROPRANOLOL 30MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 30 mg three times a day
Trial: 2859775
Drug: Propranolol 60
RxNorm normalized name: propranolol 60 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 60 mg three times a day
Trial: 2859775
Drug: Propranolol 180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 180 mg three times a day
Trial: 2859775
Drug: Acebutolol 1
RxNorm normalized name: acebutolol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acebutolol 1 mg/kg infused over 15 minutes
Trial: 20980998
Drug: Twice-weekly kisspeptin-54
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-weekly kisspeptin-54 (KP-54) injections for 8 weeks
Trial: 20980998
Drug: Twice-daily kisspeptin-54
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily kisspeptin-54 (KP-54) injections
Trial: 18591698
Drug: Flurbiprofen axetil
RxNorm normalized name: Flurbiprofen axetil
DrugBank: Flurbiprofen axetil (DB14938)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flurbiprofen axetil (FA) 1 mg.kg(‐1) iv, 30 min before and six hours after skin incision
Trial: 17380846
Drug: Dihydropyridines (DHP)
RxNorm normalized name: 4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsäuredimethylester
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dihydropyridines (DHP) treatment
Trial: 8646827
Drug: Enalaprilat infusion
RxNorm normalized name: Enalaprilat
DrugBank: Enalaprilat (DB09477)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Enalaprilat infusion in small dorsal hand veins at skin temperatures < 29.0 degrees C
Trial: 8646827
Drug: Enalaprilat infusion
RxNorm normalized name: Enalaprilat
DrugBank: Enalaprilat (DB09477)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Enalaprilat infusion in small dorsal hand veins at skin temperatures > 31 degrees C with norepinephrine preconstriction
Trial: 8646827
Drug: Insulin-mediated vasodilation
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin-mediated vasodilation
Trial: 1633323
Drug: ASA 300
RxNorm normalized name: ASA 300 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASA 300 mg daily
Trial: 1633323
Drug: ASA 500
RxNorm normalized name: ASA 500 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASA 500 mg twice daily
Trial: 6500225
Drug: Nicardipine 20
RxNorm normalized name: nicardipine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine 20 mg four times a day
Trial: 31704789
Drug: Erector spinae
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erector spinae plane block (ESPB) with continuous infusion of 0.2% levobupivacaine (8 mL/hour) after a 20 mL bolus.
Trial: 31704789
Drug: Thoracic paravertebral
RxNorm normalized name: Thoracol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thoracic paravertebral block (TPVB) with continuous infusion of 0.2% levobupivacaine (8 mL/hour) after a 20 mL bolus.
Trial: 29190357
Drug: Telephone-based cognitive-behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telephone-based cognitive-behavioral therapy (CBT), 12 sessions of 50 minutes each over 6 months
Trial: 25104527
Drug: Edoxaban high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edoxaban high dose
Trial: 25104527
Drug: Edoxaban low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edoxaban low dose
Trial: 7751734
Drug: Lomefloxacin (LFLX)
DrugBank: Lomefloxacin (DB00978)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lomefloxacin (LFLX) 100 mg or 300 mg, administered as a single dose.
Trial: 2303583
Drug: Ibuprofen/codeine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen/codeine
Trial: 2303583
Drug: Aspirin/codeine
RxNorm normalized name: ASPIRIN/CODEINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin/codeine
Trial: 2303583
Drug: All active
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All active treatment groups (including ibuprofen/codeine and aspirin/codeine)
Trial: 30553570
Drug: MF59-adjuvanted A(H5N1)
RxNorm normalized name: Influenza A monovalent (H5N1), ADJUVANTED-2013
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MF59-adjuvanted A(H5N1) vaccine
Trial: 30553570
Drug: Unadjuvanted A(H5N1)
RxNorm normalized name: influenza A virus (H5N1) antigen Prefilled Syringe [Audenz]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unadjuvanted A(H5N1) vaccine
Trial: 30553570
Drug: A(H5N1) vaccine
RxNorm normalized name: hepatitis A vaccine (inactivated) strain HM175 Injection [Havrix]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A(H5N1) vaccine antigen
Trial: 25133644
Drug: 36 hours
RxNorm normalized name: methylphenidate
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 36 hours after hCG injection
Trial: 25133644
Drug: 42 hours
RxNorm normalized name: deutetrabenazine
DrugBank: Deutetrabenazine (DB12161)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 42 hours after hCG injection
Trial: 25133644
Drug: 48 hours
RxNorm normalized name: deutetrabenazine
DrugBank: Deutetrabenazine (DB12161)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 48 hours after hCG injection
Trial: 21546726
Drug: Primary closure
RxNorm normalized name: Sodium primary phosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primary closure with omental patch
Trial: 19366848
Drug: Nestorone (NES)
RxNorm normalized name: Ne
DrugBank: Segesterone acetate (DB14583)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nestorone (NES) gel 2 mg
Trial: 19366848
Drug: Nestorone (NES)
RxNorm normalized name: Ne
DrugBank: Segesterone acetate (DB14583)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nestorone (NES) gel 4 mg
Trial: 19366848
Drug: Testosterone (T)
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone (T) gel 10 g
Trial: 19366848
Drug: T gel
RxNorm normalized name: Joint Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T gel 10 g plus NES gel 2 mg
Trial: 19366848
Drug: T gel
RxNorm normalized name: Joint Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T gel 10 g plus NES gel 4 mg
Trial: 19366848
Drug: T gel
RxNorm normalized name: Joint Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T gel 10 g plus NES gel 6 mg
Trial: 19366848
Drug: T gel
RxNorm normalized name: Joint Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T gel 10 g plus NES gel 8 mg
Trial: 18190254
Drug: Recombinant EBV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant EBV subunit glycoprotein 350 (gp350)/aluminum hydroxide and 3‐O‐desacyl‐4'‐monophosphoryl lipid A (AS04) candidate vaccine in a 3-dose regimen
Trial: 11480325
Drug: Low-sodium hypotonic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-sodium hypotonic oral rehydration solution (LSORS)
Trial: 11480325
Drug: Standard WHO
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard WHO oral rehydration solution (STORS)
Trial: 7974683
Drug: Albendazole treatment
RxNorm normalized name: Albendazole
DrugBank: Albendazole (DB00518)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Albendazole treatment alone (ABZ CE group)
Trial: 2786292
Drug: Leucovorin calcium
RxNorm normalized name: Leucovorin Calcium
DrugBank: Leucovorin (DB00650)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Leucovorin calcium 25 mg (formulation 1)
Trial: 2786292
Drug: Leucovorin calcium
RxNorm normalized name: Leucovorin Calcium
DrugBank: Leucovorin (DB00650)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Leucovorin calcium 25 mg (formulation 2)
Trial: 5795804
Drug: Pentazocine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentazocine (10 mg, 20 mg, 40 mg)